The predictive value of endometrial thickness in patients receiving tamoxifen

Journal of Pelvic Surgery

Volumn 6, Issue 1, 2000, Pages 16-19

  Lucente, Vincent R ^a   Navarro, Norman F ^a   Dupree, William B ^a   Klasko, Stephen K ^a   Reed, James F ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004599761     PISSN: 10772847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Breast Cancer Trials Committee, Scottish Cancer Trials Office. Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet 1:759, 1987.
2. Jordan VC. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31:27, 1994.
3. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 311:1391, 1995.
4. Kedar RP, Bourne TH, Povvles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343: 1318, 1994.
5. Powles TJ, Jones AL, Ashley SE, et al. The Royal Marsden Hospital pilot tamoxifen chcmoprevention trial. Breast Cancer Res Treat 31:73, 1994.
6. Gotzinger P, Gnat M, Hochstoger E, et al. The potential impact of tamoxifen in breast cancer prevention. Onkolo-gie 16:297, 1993.
7. Friedl A, Jordan VC. What do we know and what don’t we know about tamoxifen in the human uterus? Breast Cancer Res Treat 31:27, 1994.
8. Cohen I, Rosen JD, Shapira J, et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 100:567, 1993.
9. Ugwumadu A. Endometrial changes and lesions in postmenopausal women treated with tamoxifen. Br J Obstet Gynaecol 100:704, 1993.
10. Uziely B, Lcwin A, Brufman G, et al. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26:101, 1993.
11. Lahti E, Blanco G, Kauppila A, et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660, 1993.
12. Nevcn P. Tamoxifen and endometrial lesions. Lancet 342: 452, 1993.
13. Neven P, Aleem FA, Predanic M. Endometrial changes in patients on tamoxifen. Lancet 346:1292, 1995.
14. Cohen I, Rosen JD, Shapira J, et al. Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and non-treated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185, 1994.
15. Anteby E, Yagel S, Zacut D, Palti Z, Hochner-Cclniker D. False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. Lancet 340:433, 1992.
16. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447, 1994.
17. Bornstein J, Auslender R, Pascal B, Gutterman E, Isakov D, Abramovici H. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen. J Re-prod Med 39:674, 1994.
18. Timor-Tritsch IE, Rottem S, Bolds R. Scanning the uterus. In Timor-Tritsch IE, Rottem S (eds): Transvaginal Sonography. New York, Elsevier North-Holland, 1988, p. 27.
19. Nasri MN, Coast GJ. Correlation of ultrasound findings and endometrial histopathology in postmenopausal women. Br J Obstet Gynaecol 96:1333, 1989.
20. Nasri MN, Shepherd JH, Setchell ME, et al. The role of vagina scanning in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 98:470,1991.
21. Varner RE, Sparks JM, Cameron DC, et al. Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 78:195, 1991.
22. Goldstein SR, Nachtigall M, Snyder JR. Nachtigall L. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119, 1990.
23. Nasri MN, Shepherd JH, Setchell ME, et al. Sonographic depiction of postmenopausal endometrium with transabdominal and transvaginal scanning. Ultrasound Obstet Gynecol 1:279, 1991.
24. Ross LD. Pelvic ultrasound: Should it be used routinely in the diagnosis and screening of postmenopausal bleeding? J R Soc Med 81:723, 1988.
25. Lin MC, Gosnik BB, Wolf SL, et al. Endometrial thickness after menopause: Effect of hormone replacement. Radiology 180:427, 1991.
26. Cohen I, Rosen D, Tcpper R, et al. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 5:275, 1993.
27. Corley D, Rowe J, Curtis MT, et al. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111, 1992.
28. Achiron R, Lipitz S, Sivan E, Goldenberg M, Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 4:685, 1995.
29. Bourne TH, Lawton F, Leather A. Use of intracavitary saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol 4:73, 1994.
30. Gransberg S, Wikland M, Karlsson B, et al. Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164:47, 1991.
31. Osmers R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma. Lancet 335: 1569, 1990.